
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Document Content</title>
    <style>
        body { font-family: Arial, sans-serif; line-height: 1.6; max-width: 900px; margin: auto; padding: 20px; }
        table { border-collapse: collapse; width: 100%; margin-top: 20px; margin-bottom: 20px; }
        th, td { border: 1px solid #cccccc; text-align: left; padding: 8px; font-size: 12px; }
        tr:nth-child(even) { background-color: #f9f9f9; }
        th { background-color: #3366CC; color: white; font-weight: bold; }
        h2 { color: #4F81BD; border-bottom: 2px solid #4F81BD; padding-bottom: 5px;}
        p { margin-block-start: 0.5em; margin-block-end: 0.5em; }
    </style>
</head>
<body>
    <p style="font-size: small; color: grey;"><i>Document</i></p>
<p style="font-size: small; color: grey;"><i>Page 47 of 123</i></p>
<p style="font-size: small; color: grey;"><i>AKORN_10k_047.pdf</i></p>
<p>AKORN, INC. CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#x27; EQUITY FOR THE YEARS ENDED DECEMBER 31, 2015, 2016 AND 2017 (In Thousands)</p>

<table>
	<tr>
		<th rowspan="2"></th>
		<th colspan="2">Common Stock</th>
		<th rowspan="2">Retained Earnings</th>
		<th rowspan="2">Other Comprehensive Loss</th>
		<th rowspan="2">Total</th>
	</tr>
	<tr>
		<th>Shares</th>
		<th>Amount</th>
	</tr>
	<tr>
		<td>BALANCES AT DECEMBER 31, 2014</td>
		<td>111,735</td>
		<td>$ 342,252</td>
		<td>$ 29,250</td>
		<td>$ (15,195)</td>
		<td>$ 356,307</td>
	</tr>
	<tr>
		<td>Consolidated net income</td>
		<td>—
</td>
		<td>—
</td>
		<td>150,798</td>
		<td>—
</td>
		<td>150,798</td>
	</tr>
	<tr>
		<td>Exercise of stock options</td>
		<td>2,514</td>
		<td>10,503</td>
		<td>—
</td>
		<td>—
</td>
		<td>10,503</td>
	</tr>
	<tr>
		<td>Employee stock purchase plan issuances</td>
		<td>66
</td>
		<td>1,413</td>
		<td>—
</td>
		<td>—
</td>
		<td>1,413</td>
	</tr>
	<tr>
		<td>Restricted stock units</td>
		<td>16</td>
		<td>3,814</td>
		<td>—
</td>
		<td>—
</td>
		<td>3,814</td>
	</tr>
	<tr>
		<td>Stock-based compensation expense</td>
		<td>—
</td>
		<td>9,183</td>
		<td>—
</td>
		<td>—
</td>
		<td>9,183</td>
	</tr>
	<tr>
		<td>Foreign currency translation loss</td>
		<td>—
</td>
		<td>—
</td>
		<td>—
</td>
		<td>(2,051)</td>
		<td>(2,051)</td>
	</tr>
	<tr>
		<td>Excess tax benefit - stock compensation</td>
		<td>—
</td>
		<td>47,997</td>
		<td>—
</td>
		<td>—
</td>
		<td>47,997</td>
	</tr>
	<tr>
		<td>Unrealized holding loss on available-for-sale securities</td>
		<td>—
</td>
		<td>—
</td>
		<td>—
</td>
		<td>104</td>
		<td>104</td>
	</tr>
	<tr>
		<td>Convertible note conversions</td>
		<td>5,096</td>
		<td>43,497</td>
		<td>—
</td>
		<td>—
</td>
		<td>43,497</td>
	</tr>
	<tr>
		<td>Exercise of warrants</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>BALANCES AT DECEMBER 31, 2015</td>
		<td>119,427</td>
		<td>$ 458,659</td>
		<td>$ 180,048</td>
		<td>$ (17,142)</td>
		<td>$ 621,565</td>
	</tr>
	<tr>
		<td>Consolidated net income</td>
		<td>—</td>
		<td>—</td>
		<td>184,243</td>
		<td>—</td>
		<td>184,243</td>
	</tr>
	<tr>
		<td>Common stock repurchases</td>
		<td>(1,808)</td>
		<td>—
</td>
		<td>(45,000)</td>
		<td>—
</td>
		<td>(45,000)</td>
	</tr>
	<tr>
		<td>Exercise of stock options</td>
		<td>1,792</td>
		<td>13,953</td>
		<td>—
</td>
		<td>—
</td>
		<td>13,953</td>
	</tr>
	<tr>
		<td>Restricted stock units</td>
		<td>184</td>
		<td>4,091</td>
		<td>—
</td>
		<td>—
</td>
		<td>4,091</td>
	</tr>
	<tr>
		<td>Stock-based compensation expense</td>
		<td>—
</td>
		<td>11,321</td>
		<td>—
</td>
		<td>—
</td>
		<td>11,321</td>
	</tr>
	<tr>
		<td>Foreign currency translation loss</td>
		<td>—
</td>
		<td>—
</td>
		<td>—
</td>
		<td>(1,941)</td>
		<td>(1,941)</td>
	</tr>
	<tr>
		<td>Excess tax benefit - stock compensation</td>
		<td>(138)
</td>
		<td>(4,158)</td>
		<td>—</td>
		<td>—</td>
		<td>(4,158)</td>
	</tr>
	<tr>
		<td>Unrealized holding loss on available-for-sale securities</td>
		<td>—
</td>
		<td>—
</td>
		<td>—
</td>
		<td>740</td>
		<td>740</td>
	</tr>
	<tr>
		<td>Convertible note conversions</td>
		<td>4,933</td>
		<td>43,215</td>
		<td>—
</td>
		<td>—
</td>
		<td>43,215</td>
	</tr>
	<tr>
		<td>Akorn AG pension liability adjustment</td>
		<td>—</td>
		<td>—
</td>
		<td>—
</td>
		<td>(3,624)</td>
		<td>(3,624)</td>
	</tr>
	<tr>
		<td>Other</td>
		<td>—
</td>
		<td>$ (5,221)</td>
		<td>$ —
</td>
		<td>$ —</td>
		<td>$ (5,221)</td>
	</tr>
	<tr>
		<td>BALANCES AT DECEMBER 31, 2016</td>
		<td>124,390</td>
		<td>$ 521,860</td>
		<td>$ 319,291</td>
		<td>$ (21,967)</td>
		<td>$ 819,184</td>
	</tr>
	<tr>
		<td>Consolidated net loss</td>
		<td>—</td>
		<td>—</td>
		<td>(24,550)</td>
		<td>—
</td>
		<td>(24,550)</td>
	</tr>
	<tr>
		<td>Exercise of stock options</td>
		<td>625</td>
		<td>9,673</td>
		<td>—
</td>
		<td>—</td>
		<td>9,673</td>
	</tr>
	<tr>
		<td>Restricted stock units</td>
		<td>138</td>
		<td>7,736</td>
		<td>—
</td>
		<td>—</td>
		<td>7,736</td>
	</tr>
	<tr>
		<td>Stock-based compensation expense</td>
		<td>—
</td>
		<td>13,282</td>
		<td>—
</td>
		<td>—
</td>
		<td>13,282</td>
	</tr>
	<tr>
		<td>Foreign currency translation gain</td>
		<td>—
</td>
		<td>—</td>
		<td>—
</td>
		<td>6,150</td>
		<td>6,150</td>
	</tr>
	<tr>
		<td>Stock compensation plan withholdings for employee taxes</td>
		<td>(62)
</td>
		<td>(2,079)</td>
		<td>—
</td>
		<td>—</td>
		<td>(2,079)</td>
	</tr>
	<tr>
		<td>Unrealized holding loss on available-for-sale securities</td>
		<td>—
</td>
		<td>—
</td>
		<td>—
</td>
		<td>267</td>
		<td>267</td>
	</tr>
	<tr>
		<td>Akorn AG pension liability adjustment</td>
		<td>—
</td>
		<td>—
</td>
		<td>—
</td>
		<td>1,582</td>
		<td>1,582</td>
	</tr>
	<tr>
		<td>Other</td>
		<td></td>
		<td></td>
		<td>—
</td>
		<td>—</td>
		<td>—</td>
	</tr>
	<tr>
		<td>BALANCES AT DECEMBER 31, 2017</td>
		<td>125,091</td>
		<td>$ 550,472</td>
		<td>$ 294,741</td>
		<td>$ (13,968)</td>
		<td>$ 831,245</td>
	</tr>
</table>
<p>See notes to the consolidated financial statements.</p>
<p style="font-size: small; color: grey;"><i>47</i></p>
<p style="font-size: small; color: grey;"><i>file://usmdcvdi003.us.kworld.kpmg.com/GDC_Ops/Operations/Gayathri%20Krishnan/RPA%20Phase%20II/Kiran/HealthCare/ ... 7/23/2018</i></p>

</body>
</html>
